psychiatry world belatedly exhibiting outrage toward man whose ability lure pharma cash seems know bounds may textbook case key opinion leader course i speak charles bling bling nemeroff rather list many questionable best behaviors exhibited called question standing scientist opposed blatant drug marketer i want direct everyone detailed list speaking engagements glaxosmithkline discuss month living high life nemeroff style well known nemeroff appears particularly forthcoming huge amounts making moonlighting every drug company planet see despite requirements according psychiatrist danny carlat gsk paid nemeroff total note research grant money money emory psychiatry department fees went personal bank account earned either sitting gsk advisory board speaking doctors gsk products typical fee talk plus expenses sometimes made total amount disclosed emory employer required report income according gsk document hosted senator charles grassley nemeroff took grand one month speaking engagements gsk bad work get eh month seem unusual nemeroff speeches gsk also gave speeches several companies document goes pages paid speech listings nearly featuring nemeroff i picked first pages document covers expenses dr bling bling nemeroff gsk honoraria march april date speaking fee includes 'expenses i suspect speaking fee total probably excluding travel expenses imagine making k month basically reading slides times quite possibly entirely written drug company many talks accompanied posh meals kind myself readers might eat twice year nemeroff disclosure recent journal article dr nemeroff received grants performed research american foundation suicide prevention astrazeneca bristol myers squibb forest laboratories inc janssen pharmaceutica narsad themental health research association national institute mental health pfizer pharmaceuticals wyeth ayerst laboratories consultant abbott laboratories acadia pharmaceuticals bristol myers squibb corcept therapeutics cypress bioscience cyberonics eli lilly co entrepreneur fund forest laboratories inc glaxosmithkline i dln janssen pharmaceutica lundbeck otsuka america pharmaceutical inc pfizer pharmaceuticals quintiles transnational ucb pharma wyeth ayerst laboratories speakers bureau abbott laboratories glaxosmithkline janssen pharmaceutica pfizer pharmaceuticals stockholder acadia pharmaceuticals corcept therapeutics cypress bioscience novadel pharma inc board directors american foundation suicide prevention american psychiatric institute research education george west mental health foundation novadel pharma inc national foundation mental health holds patents method devices transdermal delivery lithium method estimate serotonin norepinephrine transporter occupancy drug treatment using patient animal serum provisional filing april holds equity reevax bmc jr llc cenerx i make ed silverman wrote pharmalot also raises question find time anything else